These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33249235)

  • 1. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.
    Hahnel SR; Dilks CM; Heisler I; Andersen EC; Kulke D
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():237-248. PubMed ID: 33249235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics.
    Sepúlveda-Crespo D; Reguera RM; Rojo-Vázquez F; Balaña-Fouce R; Martínez-Valladares M
    Med Res Rev; 2020 Sep; 40(5):1715-1753. PubMed ID: 32166776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
    Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
    PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary Approaches with Free-living and Parasitic Nematodes to Understanding Anthelmintic Resistance.
    Wit J; Dilks CM; Andersen EC
    Trends Parasitol; 2021 Mar; 37(3):240-250. PubMed ID: 33317926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylum-Spanning Neuropeptide GPCR Identification and Prioritization: Shaping Drug Target Discovery Pipelines for Nematode Parasite Control.
    Atkinson LE; McCoy CJ; Crooks BA; McKay FM; McVeigh P; McKenzie D; Irvine A; Harrington J; Rosa BA; Mitreva M; Marks NJ; Maule AG; Mousley A
    Front Endocrinol (Lausanne); 2021; 12():718363. PubMed ID: 34659113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping resistance-associated anthelmintic interactions in the model nematode Caenorhabditis elegans.
    Rehborg EG; Wheeler NJ; Zamanian M
    PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011705. PubMed ID: 37883578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
    Holden-Dye L; Walker RJ
    WormBook; 2014 Dec; ():1-29. PubMed ID: 25517625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways.
    Taylor CM; Wang Q; Rosa BA; Huang SC; Powell K; Schedl T; Pearce EJ; Abubucker S; Mitreva M
    PLoS Pathog; 2013; 9(8):e1003505. PubMed ID: 23935495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains.
    Shaver AO; Wit J; Dilks CM; Crombie TA; Li H; Aroian RV; Andersen EC
    PLoS Pathog; 2023 Apr; 19(4):e1011285. PubMed ID: 37011090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study.
    Weaver KJ; May CJ; Ellis BL
    PLoS One; 2017; 12(6):e0179376. PubMed ID: 28632749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model nematodes as a practical innovation to promote high throughput screening of natural products for anthelmintics discovery in South Asia: Current challenges, proposed practical and conceptual solutions.
    Kamal M; Mukherjee S; Joshi B; Sindhu ZU; Wangchuk P; Haider S; Ahmed N; Talukder MH; Geary TG; Yadav AK
    Mol Biochem Parasitol; 2023 Dec; 256():111594. PubMed ID: 37730126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans.
    Shanley HT; Taki AC; Nguyen N; Wang T; Byrne JJ; Ang CS; Leeming MG; Nie S; Williamson N; Zheng Y; Young ND; Korhonen PK; Hofmann A; Wells TNC; Jabbar A; Sleebs BE; Gasser RB
    Bioorg Med Chem; 2024 Jan; 98():117540. PubMed ID: 38134663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of novel heteromeric GluCl subtypes from Caenorhabditis elegans and parasitic nematodes.
    Lamassiaude N; Courtot E; Corset A; Charvet CL; Neveu C
    Br J Pharmacol; 2022 Mar; 179(6):1264-1279. PubMed ID: 34623639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caenorhabditis elegans is a useful model for anthelmintic discovery.
    Burns AR; Luciani GM; Musso G; Bagg R; Yeo M; Zhang Y; Rajendran L; Glavin J; Hunter R; Redman E; Stasiuk S; Schertzberg M; Angus McQuibban G; Caffrey CR; Cutler SR; Tyers M; Giaever G; Nislow C; Fraser AG; MacRae CA; Gilleard J; Roy PJ
    Nat Commun; 2015 Jun; 6():7485. PubMed ID: 26108372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity.
    Mathew MD; Mathew ND; Miller A; Simpson M; Au V; Garland S; Gestin M; Edgley ML; Flibotte S; Balgi A; Chiang J; Giaever G; Dean P; Tung A; Roberge M; Roskelley C; Forge T; Nislow C; Moerman D
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005058. PubMed ID: 27755544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of anthelmintic drugs in Caenorhabditis elegans neuro-muscular ion channel mutants.
    Miltsch SM; Krücken J; Demeler J; Ramünke S; Harder A; von Samson-Himmelstjerna G
    Parasitol Int; 2013 Dec; 62(6):591-8. PubMed ID: 23707730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of genomic intervals that underlie nematode responses to benzimidazoles.
    Zamanian M; Cook DE; Zdraljevic S; Brady SC; Lee D; Lee J; Andersen EC
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006368. PubMed ID: 29601575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
    Kaewintajuk K; Cho PY; Kim SY; Lee ES; Lee HK; Choi EB; Park H
    Parasitol Res; 2010 Jun; 107(1):27-30. PubMed ID: 20309581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent anthelmintic activity of a colloidal nano-silver formulation (Silversol
    Gajera G; Godse C; DeSouza A; Mehta D; Kothari V
    BMC Res Notes; 2023 Jul; 16(1):130. PubMed ID: 37400872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside.
    Wit J; Rodriguez BC; Andersen EC
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():1-8. PubMed ID: 33878514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.